Hsiu-Ching Hsu Selected Research

Hsiu-Ching Hsu Research Topics

Disease

13	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 11/2005
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2008
8	Stroke (Strokes) 01/2022 - 01/2002
6	Hypertension (High Blood Pressure) 01/2022 - 01/2002
6	Atherosclerosis 08/2012 - 03/2006
4	Obesity 01/2022 - 05/2006
4	Coronary Disease (Coronary Heart Disease) 08/2009 - 11/2005
3	Insulin Resistance 01/2022 - 11/2008
3	Atherosclerotic Plaque (Atheroma) 01/2020 - 01/2007
3	Type 2 Diabetes Mellitus (MODY) 05/2017 - 02/2008
2	Inflammation (Inflammations) 01/2020 - 01/2012
2	Hypercholesterolemia 01/2020 - 03/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 06/2016 - 11/2012
2	Heart Failure 12/2010 - 09/2009
2	Carotid Artery Diseases 09/2009 - 08/2008
2	Myocardial Infarction 03/2009 - 08/2008
2	Infarction (Infarctions) 03/2009 - 08/2008
1	Overweight 01/2022
1	Pediatric Obesity 01/2022
1	Hyperthyroidism 06/2016
1	Edema (Dropsy) 06/2016
1	Cardiomegaly (Heart Hypertrophy) 12/2014
1	Cardiotoxicity 11/2014
1	Neoplasms (Cancer) 11/2014
1	Ischemic Stroke 01/2013
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2012
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2012
1	Acute Coronary Syndrome 11/2011
1	Iron Overload 06/2011
1	Pathologic Constriction (Stenosis) 06/2011
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 12/2010
1	Chronic Renal Insufficiency 09/2010
1	Proteinuria 09/2010
1	Hypertriglyceridemia 09/2009
1	Vascular Diseases (Vascular Disease) 08/2009
1	Hyperglycemia 05/2009

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2009
6	Glucose (Dextrose)FDA LinkGeneric 05/2017 - 05/2006
6	LipidsIBA 11/2011 - 01/2002
5	ApolipoproteinsIBA 11/2012 - 01/2002
5	oxidized low density lipoproteinIBA 01/2012 - 06/2007
5	HDL CholesterolIBA 09/2009 - 04/2005
4	C-Reactive ProteinIBA 01/2020 - 05/2006
4	Fatty Acids (Saturated Fatty Acids)IBA 12/2019 - 02/2011
4	LDL CholesterolIBA 08/2012 - 11/2007
3	CholesterolIBA 01/2020 - 01/2007
3	Eicosapentaenoic AcidIBA 11/2014 - 02/2011
3	Docosahexaenoic AcidsIBA 11/2014 - 02/2011
3	Proteins (Proteins, Gene)FDA Link 01/2012 - 06/2007
3	Uric Acid (Urate)IBA 09/2010 - 11/2005
3	Adenosine Triphosphate (ATP)IBA 02/2008 - 05/2006
3	Apolipoproteins B (ApoB)IBA 11/2007 - 01/2002
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 03/2010
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2019 - 09/2013
2	CalciumIBA 06/2016 - 06/2011
2	CreatinineIBA 03/2015 - 04/2008
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2012 - 09/2009
1	Fibrinogen (Factor I)FDA Link 01/2022
1	TylosinIBA 01/2022
1	SaltsIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2020
1	CarbonIBA 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 05/2017
1	DiureticsIBA 06/2016
1	2,4-thiazolidinedione (thiazolidinedione)IBA 06/2016
1	hydroxide ionIBA 01/2015
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 12/2014
1	Natriuretic AgentsIBA 12/2014
1	Atrial Natriuretic Factor (ANF)IBA 12/2014
1	Angiotensin IIIBA 12/2014
1	Mitochondrial Uncoupling ProteinsIBA 11/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2014
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 11/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2014
1	FatsIBA 09/2013
1	Lipoproteins (Lipoprotein)IBA 11/2012
1	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 01/2012
1	low density lipoprotein inhibitorIBA 01/2012
1	N1- (2- (2,3- dihydroxyphenyl)- 5- methyl- 2- oxazoline- 4- carboxamido)- N3- (2,3- dihydroxyphenyl)- 1,3- diaminopropaneIBA 06/2011
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 02/2011
1	Collagen Type III (Type III Collagen)IBA 12/2010
1	Hemoglobins (Hemoglobin)IBA 09/2010
1	Triglycerides (Triacylglycerol)IBA 09/2009
1	Apolipoprotein A-VIBA 09/2009
1	AdipokinesIBA 09/2009
1	ApelinIBA 09/2009
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2009
1	procollagen Type III-N-terminal peptide (PIIP)IBA 09/2009
1	HomocysteineIBA 08/2009
1	human AOC3 proteinIBA 05/2009
1	Insulin (Novolin)FDA Link 11/2008
1	ElectrolytesIBA 09/2008
1	PotassiumIBA 09/2008
1	SodiumIBA 09/2008
1	Dietary SodiumIBA 09/2008

Therapy/Procedure

2	Ligation 03/2009 - 08/2008
1	Therapeutics 11/2014
1	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2009